Investigating Pragmatics in Foreign Language Learning, Teaching and Testing (Second Language Acquisition)
The IN VIVO Blog (Free subscription) | 20/11/2009
People, we seriously need to talk about Eggo Waffles. But first, a dearth of meaty deals this week has us thinking more about Bristol-Myers Squibb's share-swap/buyback/spin-off of its nutritionals unit Mead Johnson. We tried to make the point earlier this week that Bristol's move was too focused on short-term gain. Others have pointed out to us that without some sort of short-term gain to appease...
Off The Rack (Free subscription) | 18/11/2009
Alcon Entertainment/Warner Bros. Pictures Call it method hair. When Sandra Bullock dyed her naturally brunette hair a golden blonde to play real life Memphis housewife Leigh Anne Tuohy in her film The Blind Side, her family had a distinctly unfavorable reaction. “They didn’t like it at all,” Bullock told PEOPLE at the New [...]
Variety.com (Free subscription) | 12/11/2009
Book Adaptations: Alcon adapting Emily Giffin’s novel for film -- Luke Greenfield ("The Girl Next Door") has fallen for "Something Borrowed" and will direct the romance, produced by Alcon Entertainment toppers Andrew Kosove and Broderick Johnson along with Hilary Swank and Molly Smith through their 2S Films banner.
The Earth Times Online Newspaper (Free subscription) | 10/11/2009
CHICAGO - Zacks.com releases the latest Industry Outlook. Today, Zacks Equity Research discusses the Big Pharma & Biotech Industry, including Alcon (NYSE:
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Business Wire (Free subscription) | 10/11/2009
CHICAGO--(BUSINESS WIRE)--Zacks.com releases the latest Industry Outlook. Today, Zacks Equity Research discusses the Big Pharma & Biotech Industry, including Alcon (NYSE: ACL), Novartis (NYSE: NVS), Gilead Sciences (Nasdaq: GILD), Biogen Idec (Nasdaq: BIIB) and Acorda Therapeutics (Nasdaq: ACOR). A synopsis of today’s Industry Outlook is presented below. The full article can be read at http://www.zacks.com/stock/news/27081/Big+Pharma+and+Biotech....
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
The Health & Fitness Blog (Free subscription) | 07/11/2009
By Zack Rafael Do you wish you didn't have to keep using glasses and contact lenses? If so, then Lasik surgery may be exactly what you are looking for. It is a kind of vision correction surgery for the eye involving laser technology. The word 'Lasik' is an abbreviation of the phrase 'laser in situ keratomileusis'. In this procedure, a laser is used under the flap of the cornea. The shape of the cornea...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNINg
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Health Care Products Reviews (Free subscription) | 03/11/2009
My ophthalmalogist prefers the I-Cap formulation to its competitor. The daily dosage is 4 pills, which is both plus and a minus.Get more detail about Alcon ICaps Multivitamin Eye Vitamin & Mineral Support, Coated Tablets , 100 tablets. [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
MarketIntelligenceCenter.com (Free subscription) | 02/11/2009
Alcon (NYSE: ACL) ended the last trading session at $142.79. So far the stock has hit a 52-week low of $66.64 and 52-week high of $148.85. Alcon stock has been showing support around 140.22 and resistance in the 146.96 range. Technical indicators for the stock are Bullish and S&P gives ACL a positive 4 STAR (out of 5) buy rating. ACL appears on the Investors Observer Momentum Plays list. For a...
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Rocky Mount Telegram - Business (Free subscription) | 29/10/2009
OCEANPORT, N.J. (AP) — CommVault Systems Inc. reported a flat fiscal second-quarter profit as ...
Click here to see all comments
MAXIDEX DEXAMETHASONE WRNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Seattle Times (Free subscription) | 28/10/2009
Among the earnings stories for Wednesday, Oct. 28, from AP Financial News:
Star Tribune (Free subscription) | 28/10/2009
The Swiss company said surgical product revenue grew 7 percent to $739 million, and pharmaceutical revenue rose 8 percent to $659 million. Consumer eye care product revenue fell 3 percent to $216 million.
San Fransisco Chronicle (Free subscription) | 28/10/2009
Eye drug maker Alcon Inc. said Wednesday its profit fell 18 percent in the third quarter compared with a year ago, when it received a large tax benefit. Alcon's profit slipped to $515 million, or $1.71 per share, from $627 million, or $2.07 per share, in the... Sponsored Topics: Tax - Taxation - United States - Accounting - Society and Culture
Business Wire (Free subscription) | 27/10/2009
HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE:ACL) reported global sales rose 5.9 percent to $1,614 million for the third quarter of 2009, or a 9.0 percent increase excluding the impact of foreign exchange fluctuations. Net earnings for the third quarter of 2009 were $515 million, or $1.71 per diluted share. Excluding the impact of a $240 million tax benefit related to the refractive...
Click here to see all comments
MAXIDEX DEXAMETHAONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
The Business First of Louisville (Free subscription) | 23/10/2009
Potentia Pharmaceuticals, a Louisville-based startup biotechnology company, has reached an agreement to license an age-related macular degeneration drug it is working on to Alcon Research Ltd., a Swiss pharmaceutical company that focuses on eye-care products.
Click here to see all comments
MAXIDEX DEXAMETHASONE WARNING
I had eye surgery and in the post-op pack was MAXIDEX(dexamethasone) drops by ALCON LABS. Two days later I was BLIND Use Google and enter EPOCRATES...
Fiercebiotech (Free subscription) | 23/10/2009
Potentia Pharmaceuticals has signed a licensing and purchase agreement with eye drug company Alcon. Alcon gets a license to develop Potentia's leading drug candidate, POT-4, for the treatment of AMD. Potentia gains undisclosed upfront and milestone payments, which the Louisville Courier-Journal says could be worth hundreds of millions of dollars to the Kentucky-based Potentia. The agreements also...
Videos